✦ LIBER ✦

First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial

✍ Scribed by Siow Ming Lee; Iftekhar Khan; Sunil Upadhyay; Conrad Lewanski; Stephen Falk; Geraldine Skailes; Ernie Marshall; Penella J Woll; Matthew Hatton; Rohit Lal; Richard Jones; Elizabeth Toy; David Chao; Gary Middleton; Sue Bulley; Yenting Ngai; Robin Rudd; Allan Hackshaw; Chris Boshoff

Book ID: 119609040
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 314 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70412-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of bevacizumab plus erlotinib v

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial

✍ Roy S Herbst; Rafat Ansari; Frederique Bustin; Patrick Flynn; Lowell Hart; Grego 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 338 KB

Randomized, Double-Blind, Placebo-Contro

Randomized, Double-Blind, Placebo-Controlled, Phase II Trial of Sorafenib and Erlotinib or Erlotinib Alone in Previously Treated Advanced Non-Small-Cell Lung Cancer

✍ Spigel, D. R.; Burris, H. A.; Greco, F. A.; Shipley, D. L.; Friedman, E. K.; Wat 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 161 KB

Randomized, Placebo-Controlled, Phase II

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non-Small-Cell Lung Cancer

✍ Mok, T. S.K.; Wu, Y.-L.; Yu, C.-J.; Zhou, C.; Chen, Y.-M.; Zhang, L.; Ignacio, J 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 151 KB

Intercalated combination of chemotherapy

Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial

✍ Wu, Yi-Long; Lee, Jin Soo; Thongprasert, Sumitra; Yu, Chong-Jen; Zhang, Li; Ladr 📂 Article 📅 2013 🏛 The Lancet 🌐 English ⚖ 586 KB

Therapeutic vaccination with TG4010 and

Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial

✍ Elisabeth Quoix; Rodryg Ramlau; Virginie Westeel; Zsolt Papai; Anne Madroszyk; A 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 219 KB

9005 Vandetanib versus erlotinib in pati

9005 Vandetanib versus erlotinib in patients with previously treated advanced non-small-cell lung cancer (NSCLC): a randomized, double-blind phase III trial

✍ Goss, G.D.; Thongprasert, S.; Greco, F.A.; Thomas, M.; Tsai, C.M.; Sunpaweravong 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB